Product Information

NAPROXEN 375 MG TABLET is a generic product labeled by Granules Pharmaceuticals Inc., priced at $0.0561 per EA under NDC 70010013805. Its NADAC has been published 250 times since Nov 10, 2021.

FDA first approved this application on Dec 21, 1993. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAPROXEN 375 MG TABLET

Naproxen
$0.0561per EA

Strength

375 mg/1

NDC

70010013805

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

NAPROXEN

Approval Type

Generic (ANDA)

FDA Application

ANDA074140

FDA Approved

12/21/1993

TE Code

AB

On Market Since

4/15/2021

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for NAPROXEN 375 MG TABLET has been published 250 times since Nov 10, 2021, and over the history we have for it it has declined 24.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0561 per EA
All-time high$0.0781 (Apr 13, 2022)
All-time low$0.0474 (Apr 17, 2024)
52-week high$0.0607
52-week low$0.0561
Median price$0.0640
Average price$0.0642
Largest weekly change-28.8% (Apr 17, 2024)
Weeks tracked250
Tracking sinceNov 10, 2021

Price History

1W

-1.0%

1M

-1.0%

3M

-4.7%

6M

-4.1%

1Y

-7.5%

3Y

-12.9%

5Y

N/A

All

-24.8%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NAPROXEN 375 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 375 MG TABLET, manufactured by Granules Pharmaceuticals Inc., is $0.0561 per EA (NDC 70010013805), effective Aug 19, 2026.

How has the price of NAPROXEN 375 MG TABLET changed over time?

Over the history we have for it, the NADAC for NAPROXEN 375 MG TABLET has declined 24.8%. It has been tracked across 250 weekly CMS publications since Nov 10, 2021.

What are the highest and lowest recorded NADAC prices for NAPROXEN 375 MG TABLET?

Since Nov 10, 2021, the NADAC for NAPROXEN 375 MG TABLET has ranged from a low of $0.0474 (Apr 17, 2024) to a high of $0.0781 (Apr 13, 2022), with a median of $0.0640 per EA.

Are there cheaper alternatives to NAPROXEN 375 MG TABLET?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NAPROXEN 375 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures NAPROXEN 375 MG TABLET?

NAPROXEN 375 MG TABLET (NDC 70010013805) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.